Precigen Q4 EPS $(0.22) Misses $(0.17) Estimate, Sales $19.30M Beat $16.96M Estimate
Precigen Q4 EPS $(0.22) Misses $(0.17) Estimate, Sales $19.30M Beat $16.96M Estimate
Precigen (NASDAQ:PGEN) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.17) by 29.41 percent. This is a 15.38 percent increase over losses of $(0.26) per share from the same period last year. The company reported quarterly sales of $19.30 million which beat the analyst consensus estimate of $16.96 million by 13.80 percent. This is a 13.52 percent increase over sales of $17.00 million the same period last year.
Precigen (NASDAQ:PGEN) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.17) by 29.41 percent. This is a 15.38 percent increase over losses of $(0.26) per share from the same period last year. The company reported quarterly sales of $19.30 million which beat the analyst consensus estimate of $16.96 million by 13.80 percent. This is a 13.52 percent increase over sales of $17.00 million the same period last year.
Precigen(納斯達克:PGEN)公佈季度虧損(0.22美元),低於分析師普遍預期的(0.17美元)29.41%。這比去年同期每股虧損0.26美元增加了15.38%。該公司公佈季度銷售額為1930萬美元,比分析師普遍預期的1696萬美元高出13.80%。這比去年同期1700萬美元的銷售額增長了13.52%。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧